GUARD-AF trial results presented at European Society of Cardiology (ESC) Congress 2024 Leveraging iRhythm’s Zio®patch-based long-term continuous monitoring (LTCM), GUARD-AF […]
Data from Integrated Safety Analysis Across Three Clinical TrialsReinforces Robust Safety Profile of Aficamten Analysis from FOREST-HCM Demonstrates SuccessfulWithdrawal of […]
Additional Data from SEQUOIA-HCM Demonstrate Favorable Cardiac Remodelingby Cardiac MRI, Improvements in Cardiac Structure and Function by Echocardiography,Symptom Relief and […]
VANCOUVER, British Columbia, Aug. 30, 2024 (GLOBE NEWSWIRE) — Victory Square Technologies Inc. (“Victory Square” or the “Company”) (CSE:VST) (OTC:VSQTF) […]